Degenerative Disc Disease Treatment Market - Forecast(2022 - 2027)
Degenerative Disc Disease Treatment Market size is forecast to reach $1.7billion by 2025, growing at a CAGR of 9% during the forecast period 2020-2025. Degenerative Disc Disease refers to symptoms of back or neck pain caused by wear and tear on a spinal disc. Increasing cause of low back pains & neck pain in adults and increasing geriatric population are the major factors driving the growth of the market. Increase in sports and daily activities further enhance the overall market demand of degenerative disc disease treatment.
Report Coverage
The report: “Degenerative Disc Disease Treatment Market Forecast (2019-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Degenerative Disc Disease Treatment Market.
By Drugs: Ibuprofen, Naproxen and COX-2 inhibitors
By Treatment Type: Occupational Therapy, Physical Therapy, Special Exercises, Medications, Losing Weights and Surgery
By End Users: Hospitals, Clinics and Others
By Geography: North America, Europe, Asia Pacific and Rest of the World.
Key Takeaways
Europe dominates the Degenerative Disc Disease Treatment Market in 2019 owing to increasing suffering from lumbar degenerative spine diseases and lower back pain. The degenerative disc disease treatment market scope for different regions will be provided in the final report.
Increasing radicular pain and numbness is likely to aid in the market growth of degenerative disc disease treatment market.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Degenerative Disc Disease Treatment Market report.
High cost associated with degenerative disc disease treatments such as artificial disc replacement and spinal fusion create hurdles for the Degenerative Disc Disease Treatment Market
Drug- Segment Analysis
The Ibuprofen segment held the largest share in the Degenerative Disc Disease Treatment Market in 2019 and is estimated to grow at a CAGR of 6.3% during the forecast period 2020-2025. Ibuprofen is a medication in the nonsteroidal anti-inflammatory drug class that is used for treating pain, fever and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. Naproxen also known as Aleve is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis and fever and is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours. Naproxen sodium is available as both an immediate release and as an extended release tablet. The extended release formulations take longer to take effect than the immediate release formulations and therefore are less useful when immediate pain relief is desired. Extended release formulations are more useful for the treatment of chronic or long-lasting, conditions in which long-term pain relief is desirable.
Treatment Type- Segment Analysis
Occupational Therapy segment held the largest share in the Degenerative Disc Disease Treatment Market in 2019. Occupational therapy is for back pain and focuses on using proper body mechanics which include using larger joints in movement, conserving energy by balancing work and rest, and listening to pain signals to avoid overexertion. Specific movements make the muscles in neck and back stronger and more flexible. This supports the spine. In most cases, physical therapy and pain medication are enough for long term relief.
Geography - Segment Analysis
Europe dominated the degenerative disc disease treatment market in 2019 with a share of more than 39%, followed by Asia Pacific owing to the increasing suffering from lumbar degenerative spine diseases and lower back pain.
However, Asia-Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025 .This is attributed to the increasing population that is vulnerable to diseases along with the increasing usage of non-surgical methods for treating degenerative disc disease treatment.
Drivers – Degenerative Disc Disease Treatment Market
Increasing cause of low back pains & neck pain in adults and increasing geriatric population
Increasing cause of low back pains & neck pain in adults and increasing geriatric population is increasing the growth of the degenerative disc disease treatment market. Degenerative disc disease is one of the most common causes of low back and neck pain. It refers to symptoms of back or neck pain caused by wear-and-tear on a spinal disc. It typically consists of a low-level chronic pain with intermittent episodes of more severe pain. Degenerative disc disease in the lumbar spine or lower back refers to a syndrome in which age related wear and tear on a spinal disc causes low back pain. Intervertebral discs are tough, fibrous structures that act as ligaments between vertebrae, absorbing pressure and providing cushioning for the spinal column. Thus, increasing the growth of the degenerative disc disease treatment market during the forecast period 2020-2025.
Increasing radicular pain and numbness
Increasing radicular pain and numbness is increasing the growth of the degenerative disc disease treatment market. Degenerative disc disease is a medical condition in which there are anatomic changes and a loss of function of varying degrees of one or more intervertebral discs of the spine of sufficient magnitude as to cause symptoms. It can cause mild to severe pain, either acute or chronic near the involved disc as well as radicular pain. Degenerative disk disease can lead to numbness and tingling in arms and legs. It can also cause leg muscles to become weak. This means the damaged disks may be affecting the nerves near the spine. Numbness is also known as paresthesia in the arm or fingers. Injecting corticosteroids into the joints of the spine called facet joints relieves inflammation and soothes irritated bones Thus, increasing the growth of the degenerative disc disease treatment market during the forecast period 2020-2025.
Challenges – Degenerative Disc Disease Treatment Market
High cost associated with degenerative disc disease treatments such as artificial disc replacement
Some of the factors that may impede the growth of the Degenerative Disc Disease Treatment Market are the high cost associated with degenerative disc disease treatments such as artificial disc replacement and spinal fusion.
Degenerative Disc Disease Treatment Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Degenerative Disc Disease Treatment Market. In 2019, Degenerative Disc Disease Treatment Market share is consolidated by the top ten players present in the market. Degenerative Disc Disease Treatment, top 10 companies are Medtronic Plc., Globus Medical Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, RTI Surgical Holdings, Inc., Cousin Biotech, Ulrich Medical USA, Inc., Fresenius Kabi AG and Abbott Laboratories among others.
Comments
Post a Comment